Literature DB >> 23681359

Erectile dysfunction may be the first clinical sign of insulin resistance and endothelial dysfunction in young men.

Fengjuan Yao1, Lijuan Liu, Yan Zhang, Yanping Huang, Donghong Liu, Hong Lin, Yanqiu Liu, Rui Fan, Cuiling Li, Chunhua Deng.   

Abstract

OBJECTIVES: The purpose of this study is to investigate the possible underlying pathogenesis of erectile dysfunction (ED) without well-known etiology in young men under the age of 40 years.
METHODS: 192 patients and 33 normal controls were enrolled. ED was evaluated by using the International Index of Erectile Function-5 (IIEF-5) questionnaire. Traditional cardiovascular risk factors, hormone levels, and vascular parameters were measured. Insulin resistance (IR) was measured by homeostasis model assessment (HOMA).
RESULTS: Patients with ED had significantly higher levels of systolic blood pressure (SBP), high-sensitivity C-reactive protein (Hs-CRP), high Insulin resistance index (HOMA-IR) and carotid intima-media thickness (IMT), compared with controls. The brachial artery endothelium-dependent flow-mediated vasodilation (FMD) values were significantly lower in ED patients. By multivariate logistic regression analysis, FMD, SBP, Hs-CRP and HOMA-IR were significantly associated with ED. In receiver-operating characteristic (ROC) analysis, FMD was a significant predictor of ED (area under the curve (AUC) 0.933, p < 0.001). The cutoff value of FMD <10.4 % had sensitivity of 81.3 % and specificity of 100 %. HOMA-IR was also proven to be predictor of ED (AUC of HOMA-IR 0.759, p < 0.001).
CONCLUSIONS: ED may be the first clinical sign of endothelial dysfunction and a clinical marker of cardiovascular and metabolic diseases. Subclinical endothelial dysfunction and insulin resistance may be the underlying pathogenesis of ED in young patients without well-known etiology. Measurement of FMD, HOMA-IR can improve our ability to predict and treat ED, as well as subclinical cardiovascular disease early in young men.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23681359     DOI: 10.1007/s00392-013-0577-y

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  27 in total

Review 1.  Insulin resistance and cardiovascular disease.

Authors:  S I McFarlane; M Banerji; J R Sowers
Journal:  J Clin Endocrinol Metab       Date:  2001-02       Impact factor: 5.958

Review 2.  The health of normally aging men: The Massachusetts Male Aging Study (1987-2004).

Authors:  Amy B O'Donnell; Andre B Araujo; John B McKinlay
Journal:  Exp Gerontol       Date:  2004-07       Impact factor: 4.032

Review 3.  Erectile dysfunction and testosterone screening with prostate specific antigen screening at age 40: are these three gender specific determinants additive for overall men's heath and do they improve traditional non-gender specific determinants to lessen cardiovascular risk and all-cause mortality?

Authors:  M M Miner; A D Seftel
Journal:  Int J Clin Pract       Date:  2010-12       Impact factor: 2.503

4.  The prevalence of erectile dysfunction in the primary care setting: importance of risk factors for diabetes and vascular disease.

Authors:  Steven A Grover; Ilka Lowensteyn; Mohammed Kaouache; Sylvie Marchand; Louis Coupal; Emidio DeCarolis; Joseph Zoccoli; Isabelle Defoy
Journal:  Arch Intern Med       Date:  2006-01-23

5.  Circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are associated with proximal/middle segment of the LAD lesions in patients with stable coronary artery disease.

Authors:  Mehmet Balın; Ahmet Celik; M Ali Kobat
Journal:  Clin Res Cardiol       Date:  2011-11-25       Impact factor: 5.460

6.  Left ventricular diastolic function and endothelial function in patients with erectile dysfunction.

Authors:  Nevzat Uslu; Mehmet Eren; Sevket Gorgulu; Ahmet T Alper; Ahmet L Orhan; Aydin Yildirim; Zekeriya Nurkalem; Huseyin Aksu
Journal:  Am J Cardiol       Date:  2006-04-27       Impact factor: 2.778

7.  Clinical correlates of endothelial function in chronic heart failure.

Authors:  Marco Matteo Ciccone; Massimo Iacoviello; Agata Puzzovivo; Pietro Scicchitano; Francesco Monitillo; Francesco De Crescenzo; Vito Caragnano; Marco Sassara; Giovanni Quistelli; Pietro Guida; Stefano Favale
Journal:  Clin Res Cardiol       Date:  2011-01-07       Impact factor: 5.460

8.  Anti-glycated albumin therapy ameliorates early retinal microvascular pathology in db/db mice.

Authors:  R S Clements; W G Robison; M P Cohen
Journal:  J Diabetes Complications       Date:  1998 Jan-Feb       Impact factor: 2.852

Review 9.  Testosterone and metabolic syndrome: a meta-analysis study.

Authors:  Giovanni Corona; Matteo Monami; Giulia Rastrelli; Antonio Aversa; Yuliya Tishova; Farid Saad; Andrea Lenzi; Gianni Forti; Edoardo Mannucci; Mario Maggi
Journal:  J Sex Med       Date:  2010-08-30       Impact factor: 3.802

Review 10.  Testosterone deficiency, insulin resistance and the metabolic syndrome.

Authors:  Michael Zitzmann
Journal:  Nat Rev Endocrinol       Date:  2009-10-27       Impact factor: 43.330

View more
  13 in total

Review 1.  Investigating the role of acute mental stress on endothelial dysfunction: a systematic review and meta-analysis.

Authors:  Yi-Tao Xue; Qi-Wen Tan; Ping Li; Shan-Fang Mou; Shu-Juan Liu; Yue Bao; Hua-Chen Jiao; Wen-Ge Su
Journal:  Clin Res Cardiol       Date:  2014-11-13       Impact factor: 5.460

2.  Effects of prolonged ingestion of epigallocatechin gallate on diabetes type 1-induced vascular modifications in the erectile tissue of rats.

Authors:  C Lombo; C Morgado; I Tavares; D Neves
Journal:  Int J Impot Res       Date:  2016-05-12       Impact factor: 2.896

Review 3.  Understanding and targeting the Rho kinase pathway in erectile dysfunction.

Authors:  Nikolai A Sopko; Johanna L Hannan; Trinity J Bivalacqua
Journal:  Nat Rev Urol       Date:  2014-10-14       Impact factor: 14.432

4.  Erectile Dysfunction in Individuals with Type 1 Diabetes is Associated with Long-term Metabolic Control and Diabetic Complications: A Cross-Sectional Study.

Authors:  Mikołaj Kamiński; Michał Kulecki; Paweł Lachowski; Dominika Kasprzak; Ania Kulczycka; Maria Kozłowska; Daria Klause; Aleksandra Uruska; Mateusz Michalski; Dorota Zozulińska-Ziółkiewicz
Journal:  Int J Angiol       Date:  2022-01-13

Review 5.  Erectile dysfunction.

Authors:  Faysal A Yafi; Lawrence Jenkins; Maarten Albersen; Giovanni Corona; Andrea M Isidori; Shari Goldfarb; Mario Maggi; Christian J Nelson; Sharon Parish; Andrea Salonia; Ronny Tan; John P Mulhall; Wayne J G Hellstrom
Journal:  Nat Rev Dis Primers       Date:  2016-02-04       Impact factor: 52.329

6.  Prevalence of thrombophilic disorders in takotsubo patients: the (ThROmbophylia in TAkotsubo cardiomyopathy) TROTA study.

Authors:  Emanuele Cecchi; Guido Parodi; Serena Fatucchi; Paola Angelotti; Cristina Giglioli; Anna Maria Gori; Brunella Bandinelli; Benedetta Bellandi; Elena Sticchi; Ilaria Romagnuolo; Lucia Mannini; David Antoniucci; Rosanna Abbate
Journal:  Clin Res Cardiol       Date:  2016-03-22       Impact factor: 5.460

7.  Carotid artery intima-media thickness and erectile dysfunction in patients with metabolic syndrome.

Authors:  Mustafa Unal; Duygu Yazgan Aksoy; Yusuf Aydın; Mine Durusu Tanriover; Dilek Berker; Jale Karakaya; Serdar Guler
Journal:  Med Sci Monit       Date:  2014-05-29

8.  Increased Risk of Dementia in Patients With Erectile Dysfunction: A Population-Based, Propensity Score-Matched, Longitudinal Follow-Up Study.

Authors:  Chun-Ming Yang; Yuan-Chi Shen; Shih-Feng Weng; Jhi-Joung Wang; Kai-Jen Tien
Journal:  Medicine (Baltimore)       Date:  2015-06       Impact factor: 1.889

9.  Erectile dysfunction is associated with subclinical carotid vascular disease in young men lacking widely-known risk factors.

Authors:  Feng-Juan Yao; Ya-Dong Zhang; Zi Wan; Wei Li; Hong Lin; Chun-Hua Deng; Yan Zhang
Journal:  Asian J Androl       Date:  2018 Jul-Aug       Impact factor: 3.285

10.  What is the best biological parameter to predict erectile dysfunction in men aged >55 years with type 2 diabetes?

Authors:  Sitraka A Raharinavalona; Nicolas Chevalier; Claude Gruel; André-Christian N'toutoum; Fritz-Line Vélayoudom Céphise
Journal:  J Diabetes Investig       Date:  2019-07-08       Impact factor: 4.232

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.